Clinical Trials Logo

Enuresis clinical trials

View clinical trials related to Enuresis.

Filter by:

NCT ID: NCT04577872 Completed - Clinical trials for Urinary Incontinence

The Effect of Pelvic Floor Exercise on Urinary Incontinence and Quality of Sex Life

Start date: January 1, 2016
Phase: N/A
Study type: Interventional

This physiotherapist-guided group training programme should be performed in both the supine and the sitting positions; it is investigated, which is better and more cost-effective in patient motivation.

NCT ID: NCT04571346 Completed - Clinical trials for Urinary Incontinence,Stress

Female Sling Procedure

Start date: January 2016
Phase: Phase 2/Phase 3
Study type: Interventional

In trans-obturator tape (TOT), tension and location of the tape in mid urethral zone are directly related to the postoperative clinical outcome. Recurrence of symptoms of stress urinary incontinence has been related to tape migration in previous studies. The study aimed to increase the success rate of TOT procedure through a new surgical technique using a 2 paramedian vaginal incisions.

NCT ID: NCT04570605 Completed - Overactive Bladder Clinical Trials

Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Pilot study for determining feasibility of home parasacral transcutaneous electrical nerve stimulation in treatment of urinary urgency and incontinence.

NCT ID: NCT04565925 Recruiting - Clinical trials for Spinal Cord Injuries

Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

Start date: July 7, 2021
Phase: Phase 2
Study type: Interventional

The goal of this study is to determine whether administration of sildenafil will decrease urine leakage in patients with spinal cord injuries.

NCT ID: NCT04558762 Not yet recruiting - Clinical trials for Stress Urinary Incontinence

Ten Years Follow-up After Insertion of a MUS (Mid Urethral Sling) Due to Stress Urinary Incontinence

Start date: September 2020
Phase:
Study type: Observational

The investigators intend to investigate the long-term complications and the subjective well-being among women who underwent insertion of a MUS due to stress urinary incontinence 2006-2010.

NCT ID: NCT04545931 Recruiting - Clinical trials for Primary Monosymptomatic Nocturnal Enuresis

Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis

PTNS
Start date: March 15, 2020
Phase: Phase 4
Study type: Interventional

Nocturnal enuresis is a worldwide health problem frequently encountered in childhood . It affects 18 % of younger school- age children in Egypt. It is the most frequent (85%) type of enuresis in children (Eberdt-Gołabek et al, 2013), . Nocturnal enuresis includes monosymptomatic nocturnal enuresis with no day time urinary symptoms and non monosymptomatic nocturnal enuresis that accompanied by day time urinary symptoms . It can cause severe psychological and social distress to children and their parents . The currently recommended treatment such as alarms , antidiuretic hormone and anticholenergics are not effective in all children with significant relapse rate . Although it's mechanism of action is not fully elucidated , posterior tibial nerve stimulation is safe and acceptable, with evidence of potential clinical effect for both bladder and bowel dysfunction (Bellette et al, 2009). This study will investigate the effect of posterior tibial nerve stimulation on primary monosymptomatic nocturnal enuresis in children.

NCT ID: NCT04531683 Not yet recruiting - Clinical trials for Urinary Incontinence, Mixed

Effect of Electroacupuncture on Mixed Urinary Incontinence Among Women

EAMUI
Start date: October 30, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the efficacy and safety of electroacupuncture on mixed urinary incontinence among women.

NCT ID: NCT04528784 Completed - Multiple Sclerosis Clinical Trials

Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis

Start date: October 14, 2020
Phase: N/A
Study type: Interventional

Neurogenic lower urinary tract dysfunction is common among people with Multiple sclerosis with a pooled prevalence of 68.41% using self-report measures and 63.95% using urodynamic studies. Transcutaneous Tibial Nerve Stimulation (TTNS) is a non-invasive treatment option to manage bladder storage symptoms, however, the potential efficacy of TTNS among people with multiple sclerosis is based on a small number of studies with the absence of high-quality evidence relating to efficacy, and lack of clarity of the optimal electrical stimulation parameters and frequency, duration and number of treatment sessions. The feasibility and acceptability of TTNS to manage storage bladder symptoms using Transcutaneous Electrical Nerve Stimulation (TENS) needs to be established before proceeding with a definitive randomised trial. This study aims to assess whether TTNS is feasible and acceptable as a treatment for bladder storage symptoms in people with MS

NCT ID: NCT04525846 Completed - Clinical trials for Urinary Incontinence

A Comparison of Urinary Incontinence During Third Trimester of Nulliparous on Pelvic Floor Muscle Training

Start date: August 23, 2019
Phase: N/A
Study type: Interventional

Comparison of urinary incontinence during third trimester of nulliparous on pelvic floor muscle training in Rajavithi hospital

NCT ID: NCT04525105 Completed - Clinical trials for Pelvic Organ Prolapse

SMAD2, SMAD3 AND TGF-β GENE EXPRESSION IN URGE URINARY INCONTINENCE

Start date: November 1, 2017
Phase:
Study type: Observational

Urge urinary incontinence (UUI) is a common health problem. Changes in collagen metabolism in pelvic support organs, such as uterosacral ligaments (USLs), might be responsible for the complex pathophysiology of UUI. The TGF-β pathway is involved in collagen synthesis and degradation. The Transforming Growth Family- β (TGF-β) superfamily has essential intracellular signaling components, such as newly identified SMAD family members. We evaluated the changes in the levels of TGF-β and SMAD gene and protein expression in the USL of patients with concomitant pelvic organ prolapse (POP) and UUI.